Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Artificial Immune Cell, AI‐cell , a New Tool to Predict Interferon Production by Peripheral Blood Monocytes in Response to Nucleic Acid Nanoparticles

Small(2022)10.1002/smll.202204941Source: DataRank Database

Artificial Immune Cell, AI‐cell , a New Tool to Predict Interferon Production by Peripheral Blood Monocytes in Response to Nucleic Acid Nanoparticles is a research paper published in Small (2022). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.06)OA: hybridTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Sankalp Jain ORCID,Justin R. Halman ORCID,Enping Hong,Marina A. Dobrovolskaia ORCID,Alexey Zakharov ORCID

Live enrichment

PubMed:36216772 PMC:PMC9671856 OpenAlex:https://openalex.org/W4304128536

National Institute of General Medical Sciences

Grant: R01GM120487

National Institute of General Medical Sciences

Grant: R35GM139587

NCI NIH HHS

Grant: 75N91019D00024

National Institutes of Health

Grant: 5R01GM120487-04

Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity

National Institutes of Health

Grant: 3R35GM139587-03S1

Administrative Supplement to SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses

FWCI

3.06

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/smll.202204941

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/smll.202204941

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202204941

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/smll.202204941

journalhttps://doi.org/10.1002/smll.202204941

Fields of Study

Advanced biosensing and bioanalysis techniquesRNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 Research0301 basic medicine0303 health sciences03 medical and health sciencesHumansNucleic AcidsMonocytesNanoparticlesInterferonsArtificial Intelligence

MeSH Terms

Artificial IntelligenceHumansInterferonsMonocytesNucleic AcidsNanoparticles

Keywords

Nucleic acidPeripheral bloodImmune systemCellMonocyteInterferonCell mediated immunityPeripheralBlood cellChemistryImmunologyCell biologyBiologyBiochemistryMedicineImmunityInternal medicineArtificial intelligenceMachine LearningRna NanotechnologyImmunorecognitionNucleic Acid Nanoparticles (Nanps)Nucleic AcidsHumansNanoparticlesInterferonsMonocytes

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being